UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                   FORM 10-Q

[X]      QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
         EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2008
                               --------------

[_]      TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES
         EXCHANGE ACT OF 1934

For the Transition Period from __________ to __________

Commission File No. 000-52910


                            CENTRACAN INCORPORATED
               ----------------------------------------------
               (Name of Small Business Issuer in Its Charter)


                   Florida                                    65-0736042
----------------------------------------                  ---------------
      (State or Other Jurisdiction                       (I.R.S. Employer
    of Incorporation or Organization)                   Identification No.)


c/o Olshan Grundman Frome et al.
65 East 55th Street, New York, New York                        10022
----------------------------------------                  ---------------
(Address of Principal Executive Offices)                    (Zip Code)


Issuer's telephone number, including area code:      (212) 451-2254


Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of  the  Exchange Act  of  1934   during  the
preceding 12 months (or for such shorter period that the registrant was required
to file such reports), and (2) has been  subject to such filing requirements for
the past 90 days.                                   Yes [X] No [  ]

Indicate  by  check  mark  whether the registrant is a large accelerated  filer,
an  accelerated  filer, a non-accelerated filer, or a smaller reporting company.

         Large accelerated filer [  ]         Accelerated filer [  ]

         Non-accelerated filer [  ]           Smaller reporting company [X]

Indicate by check mark whether the registrant is a shell company (as defined  in
Rule12b-2 of the Exchange Act).                     Yes [X] No [  ]

As of June 30, 2008, there were 392,457 shares of common stock outstanding.

                                      1

<PAGE>


                             CENTRACAN INCORPORATED
             FORM 10-Q FOR THE QUARTERLY PERIOD ENDED June 30, 2008

                               TABLE OF CONTENTS


                    PART I                                                  Page

Item 1.             FINANCIAL STATEMENTS                                      3

Item 2.             MANAGEMENT'S DISCUSSION AND ANALYSIS OR PLAN OF
                    OPERATION                                                11

Item 4T.            CONTROLS AND PROCEDURES                                  14

                    PART II

Item 1.             LEGAL PROCEEDINGS                                        14

Item 2.             UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF
                    PROCEEDS                                                 14

Item 3.             DEFAULTS UPON SENIOR SECURITIES                          14

Item 4.             SUBMISSION OF MATTERS TO A VOTE OF SECURITIY HOLDERS     14

Item 5.             OTHER INFORMATION                                        15

Item 6.             EXHIBITS                                                 15

SIGNATURES                                                                   15

EXHIBITS

                                      2


<PAGE>


                                    PART I

Item 1.  Financial Statements.


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

FINANCIAL STATEMENTS
FINANCIAL STATEMENTS AS OF JUNE 30, 2008 AND DECEMBER 31, 2007 AND FOR THE SIX
MONTHS ENDED JUNE 30, 2008 AND 2007 AND FOR THE PERIOD MARCH 21, 1997 (DATE OF
INCEPTION) THROUGH JUNE 30, 2008





                                       3
<PAGE>


MOORE & ASSOCIATES, CHARTERED
ACCOUNTANTS AND ADVISORS
PCAOB REGISTERED


              REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


To the Board of Directors
Centracan, Inc.

We have  reviewed  the  accompanying  condensed  consolidated  balance  sheet of
Centracan,  Inc. as of June 30, 2008,  and the related  condensed  statements of
operations,  stockholders' equity (deficit),  and cash flows for the three-month
and six-month  periods ended June 30, 2008 and 2007 and since inception on March
21, 1997 through June 30,  2008.  These  interim  financial  statements  are the
responsibility of the Corporation's management.

We conducted our reviews in accordance  with the standards of the Public Company
Accounting  Oversight  Board  (United  States).  A review of  interim  financial
information  consists of principally  applying analytical  procedures and making
inquiries of persons  responsible for the financials and accounting  matters. It
is  substantially  less in scope than an audit  conducted in accordance with the
standards of the Public Company Accounting  Oversight Board (United States), the
objective  of which is the  expression  of an opinion  regarding  the  financial
statements taken as a whole. Accordingly, we do not express such an opinion.

Based on our reviews, we are not aware of any material modifications that should
be made to such condensed  consolidated  financial  statements for them to be in
conformity with accounting principles generally accepted in the United States of
America.

We have previously  audited,  in accordance with standards of the Public Company
Accounting Oversight Board (United States), the balance sheet of Centracan, Inc.
as of December  31, 2007,  and the related  consolidated  statements  of income,
stockholders'  equity  and cash  flows for the year then  ended  (not  presented
herein);  and in our report  dated May 9, 2008,  we  expressed an opinion with a
going  concern  paragraph on those  financial  statements.  In our opinion,  the
information set forth in the accompanying  balance sheet as of December 31, 2007
is fairly stated,  in all material  respects,  in relations to the balance sheet
from which it has been derived.

/s/ Moore & Associates, Chartered
Moore & Associates, Chartered
Las Vegas, Nevada
August 13, 2008



2675 S. JONES BLVD. SUITE 109, LAS VEGAS, NEVADA 89146 (702) 253-7499
Fax: (702)253-7501




                                       4
<PAGE>



CENTRACAN, INC.
(A Development Stage Company)


TABLE OF CONTENTS
--------------------------------------------------------------------------------



FINANCIAL STATEMENTS AS OF JUNE 30, 2008 AND DECEMBER 31, 2007 AND FOR THE SIX
MONTHS ENDED JUNE 30, 2008 AND 2007 AND FOR THE PERIOD MARCH 21, 1997 (DATE OF
INCEPTION) THROUGH JUNE 30, 2008

Balance sheet                                                                 6

Statements of operations                                                      7

Statements of cash flows                                                     8-9

                                       5
<PAGE>



CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

BALANCE SHEETS
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>

ASSETS                                                                    JUNE 30,       DECEMBER 31,
                                                                            2008            2007
                                                                         ---------       ---------
                                                                         UNAUDITED
CURRENT ASSETS:
<S>                                                                      <C>             <C>
     Cash                                                                $    --         $      84
                                                                         ---------       ---------

     Total current assets                                                     --                84
                                                                         ---------       ---------

TOTAL ASSETS                                                             $       0       $      84
                                                                         =========       =========


LIABILITIES AND STOCKHOLDERS' DEFICIENCY


CURRENT LIABILITIES:

     Accounts payable and accrued expenses                               $  95,024       $  99,278
     Accounts payable - related party                                       19,934           6,030
     Notes payable - related party-in default                               24,409          24,409
     Notes payable - related party                                          45,450          36,600
                                                                         ---------       ---------

     Total current liabilities                                             184,817         166,317
                                                                         ---------       ---------

STOCKHOLDERS' DEFICIENCY:

     Preferred stock, par value $.0001 per share; 10,000,000 shares
       authorized; none issued and outstanding                                --              --
     as of June 30, 2008 and December 31, 2007, respectively
     Common stock, par value $.0001 per share; 50,000,000 shares
       authorized; 392,457 shares issued and outstanding                        40              40
     as of June 30, 2008 and December 31, 2007, respectively
     Additional paid-in capital                                            137,008         137,008
     Deficit accumulated during the development stage                     (321,865)       (303,281)
                                                                         ---------       ---------

       Total stockholders' deficiency                                     (184,817)       (166,233)
                                                                         ---------       ---------

       TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY                    $       0       $      84
                                                                         =========       =========
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       6
<PAGE>



CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF OPERATIONS
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
                                                   SIX MONTHS ENDED                   THREE MONTHS ENDED           FOR THE PERIOD
                                                       JUNE 30,                            JUNE 30,                MARCH 21, 1997
                                             ---------------------------         ---------------------------     (DATE OF INCEPTION)
                                                      UNAUDITED                           UNAUDITED                      TO
                                                2008              2007              2008              2007         June 30, 2008
                                             ---------         ---------         ---------         ---------     -------------------

<S>                                          <C>               <C>               <C>               <C>           <C>
DEVELOPMENT STAGE REVENUES                   $       0         $       0         $       0         $       0         $  24,728
                                             ---------         ---------         ---------         ---------         ---------

DEVELOPMENT STAGE EXPENSES:

      Accounting                                 6,500            13,200             5,000             6,600           127,371
      Advertising                                    0                 0                 0                 0            30,560
      Bank charges                                 185                50               110                50             1,115
      Consulting fees                                0                 0                 0                 0             5,082
      Legal fees                                 5,000                 0             5,000                 0            53,947
      Licenses and taxes                           200               200                 0                 0             2,782
      Meals and entertainment                        0                 0                 0                 0             5,248
      Miscellanous expenses                          0                 0                 0                 0             1,828
      Office general and printing                1,124                 0                 0                 0            10,052
      Payroll and commissions                        0                 0                 0                 0            14,430
      Shareholder related services                   0                 0                 0                 0             2,835
      Transfer agent fees                        2,387                 0             1,500                 0            21,395
                                             ---------         ---------         ---------         ---------         ---------
TOTAL DEVELOPMENT STAGE EXPENSES                15,396            13,450            11,610             6,650           276,645
                                             ---------         ---------         ---------         ---------         ---------

      LOSS FROM OPERATIONS                     (15,396)          (13,450)          (11,610)           (6,650)         (251,917)

      LOSS ON INVESTMENT - HEALTHCARE                0                 0                 0                 0           (50,016)

      INTEREST EXPENSE                          (3,189)           (2,427)           (1,635)           (1,289)          (19,932)
                                             ---------         ---------         ---------         ---------         ---------


      NET LOSS                               $ (18,585)        $ (15,877)        $ (13,245)        $  (7,939)        $(321,865)
                                             =========         =========         =========         =========         =========

LOSS PER COMMON SHARE
      Basic & diluted                        $   (0.05)        $   (0.04)        $   (0.03)        $   (0.02)
                                             =========         =========         =========         =========
Weighted-average number of common
 shares outstanding                            392,457           392,457           392,457           392,457
                                             =========         =========         =========         =========
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       7
<PAGE>



CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

STATEMENTS OF CASH FLOWS
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
                                                                            SIX MONTHS ENDED                FOR THE PERIOD
                                                                                JUNE 30,                    MARCH 21, 1997
                                                                               UNAUDITED                  (DATETOF INCEPTION)
OPERATING ACTIVITIES                                                  2008                  2007           To JUNE 30, 2008
                                                                   ---------             ---------        -------------------
<S>                                                                <C>                   <C>              <C>
Net loss                                                           $ (18,585)            $ (15,877)            $(321,865)

Adjustment to reconcile net loss to net cash
used by operations
      Shares issued for consulting services                                0                     0                36,148
      Shares issued for termination of HMC                                 0                     0                50,000

Changes in assets and liabilities
      Increase in accounts payable and accrued expenses               (4,254)                6,627                95,024
      Increase in accounts payable and accrued expenses
      related party                                                   13,905                     0                19,934
                                                                   ---------             ---------             ---------

      Net cash used by operating activities                           (8,934)               (9,250)             (120,759)
                                                                   ---------             ---------             ---------

FINANCING ACTIVITES
      Proceeds from promissory notes                                   8,850                 7,000                69,859
      Proceeds from issuance of common stock                               0                     0                50,900
                                                                   ---------             ---------             ---------

      Net cash provided by financing activites                         8,850                 7,000               120,759
                                                                   ---------             ---------             ---------

INCREASE  IN CASH                                                        (84)               (2,250)                    0

CASH, BEGINNING OF PERIOD                                                 84                 2,484                     0
                                                                   ---------             ---------             ---------

CASH, END OF PERIOD                                                $       0             $     234             $       0
                                                                   =========             =========             =========
</TABLE>


   The accompanying notes are an integral part of these financial statements.

                                       8
<PAGE>



CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

STATEMENT OF CASH FLOWS (continued)
--------------------------------------------------------------------------------
<TABLE>
<CAPTION>
                                                                            SIX MONTHS ENDED                FOR THE PERIOD
                                                                                JUNE 30,                    MARCH 21, 1997
                                                                               UNAUDITED                  (DATETOF INCEPTION)
OPERATING ACTIVITIES                                                  2008                  2007           To JUNE 30, 2008
                                                                   ---------             ---------        -------------------
<S>                                                                <C>                   <C>              <C>
Supplemental cash flow information:
     Interest paid                                                 $       0             $       0             $       0
                                                                   =========             =========             =========

     Income taxes paid                                             $       0             $       0             $       0
                                                                   =========             =========             =========

Noncash investing and financing activities:
     Shares issued to founder for consulting servics               $       0             $       0             $      81
                                                                   =========             =========             =========

     Shares issued for legal services rendered                     $       0             $       0             $     500
                                                                   =========             =========             =========
</TABLE>


    The accompanying notes are an integral part of these financial statements.

                                       9
<PAGE>


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------

1.       DESCRIPTION OF BUSINESS

         Premier  Supplements,  Corp.  ("the Company") was incorporated on March
         21,  1997 under the laws of the State of  Florida.  On May 15, 1998 the
         Company  changed its name to Centracan,  Inc. The Company's  operations
         have been devoted  primarily to structuring and  positioning  itself to
         take  advantage  of  opportunities   available  in  the  pharmaceutical
         industry.  The Company  intends to grow through  internal  development,
         strategic alliances and acquisitions of existing business.  The Company
         is a development stage company and has had limited activity.

         GOING CONCERN

         The  accompanying  financial  statements  have been prepared on a going
         concern basis,  which  contemplates  the  realization of assets and the
         satisfaction  of  liabilities  in the  normal  course of  business.  As
         reflected in the financial  statements,  development  stage losses from
         March 21, 1997  (inception)  to June 30, 2008  aggregated  $321,865 and
         raise  substantial  doubt about the Company's  ability to continue as a
         going concern.  The Company's cash flow requirements during this period
         have  been  met  by   contributions  of  capital  and  debt  financing.
         Management's  plans  include  the  potential  development  of  its  own
         business or merging with an operating company.  The Company anticipates
         that  financing  will be required  until such time that the Company has
         been able to develop  its own  business or find an  appropriate  merger
         candidate.  Currently,  the Company can not determine  when either will
         occur and as such the Company  will need to obtain  financing  to cover
         its costs for the  foreseeable  future.  No assurance can be given that
         these  sources of  financing  will  continue  to be  available.  If the
         Company is unable to generate  profits,  or unable to obtain additional
         funds for its working capital needs, it may have to cease operations.

         The financial statements do not include any adjustments relating to the
         recoverability  and  classification of assets or liabilities that might
         be  necessary  should  the  Company  be unable to  continue  as a going
         concern.

2.       ACCOUNTS PAYABLE AND ACCRUED EXPENSES

         Accounts payable and accrued expenses at June 30, 2008 and December 31,
         2007 consisted of the following:

                                                         June 30,   December 31,
                                                           2008          2007
                                                        --------      --------
         Accrued expenses, primarily professional fees  $ 95,024      $ 88,564
         Accrued interest                                 19,934        16,745
                                                        --------      --------

         Total accounts payable and accrued expenses    $114,958      $105,309
                                                        ========      ========


                                       10
<PAGE>


CENTRACAN, INC.
(A DEVELOPMENT STAGE COMPANY)

NOTES TO FINANCIAL STATEMENTS
--------------------------------------------------------------------------------


3.       NOTE PAYABLE - RELATED PARTY

         Through June 30, 2008, the Company  executed notes  aggregating a total
         of $69,859.  These notes include short-term  borrowings of $45,450 with
         maturities  of less  then one  year  with an  interest  rate of 10% and
         long-term  borrowings  which matured on January 1, 2007 and an interest
         rate  of  10%.  Matured  borrowing  continue  to  earn  interest  after
         maturity,  similar  to  short-term  debt.  These  short-term  notes are
         convertible  into shares of common stock at any time at the  conversion
         rate of $.01 per share.  The value of the  conversion  feature  was not
         considered  material.  Long-term  borrowings  for  June  30,  2008  and
         December 31, 2007 are $24,409 and $24,409, respectively.






                                       11
<PAGE>


Item 2.  Management's Discussion and Analysis


The following plan of operation provides  information which management  believes
is relevant to an assessment and  understanding of our results of operations and
financial  condition.  The  discussion  should be read along with our  financial
statements and notes thereto.  Centracan,  Inc. is a development  stage company.
Because the Company has not generated any revenue, it intends to report its plan
of operation below.

The following discussion and analysis contains forward-looking statements, which
involve  risks and  uncertainties.  The  Company's  actual  results  may  differ
significantly  from the  results,  expectations  and  plans  discussed  in these
forward-looking statements.

The Company's  operations  have been devoted  primarily to developing a business
plan and raising capital for future operations and administrative functions. The
Company intends to grow through internal development,  strategic alliances,  and
acquisitions of existing  businesses.  Because of uncertainties  surrounding its
development,  the Company anticipates  incurring development stage losses in the
foreseeable  future.  The  ability  of  the  Company  to  achieve  its  business
objectives is contingent  upon its success in raising  additional  capital until
adequate revenues are realized from operations.

PERIOD FROM MARCH 21, 1997 (DATE OF INCEPTION) THROUGH JUNE 30, 2008

Our cumulative net losses since the inception are  attributable to the fact that
we have  not  derived  any  revenue  from  operations  to  offset  out  business
development expenses.

Losses from  operations  since  inception  have  amounted to $321,865  primarily
consisting of accounting, legal and transfer agent fees.

SIX MONTHS ENDED JUNE 30, 2008 AND JUNE 30, 2007
Development stage expenses and interest expense during the six months ended June
30, 2008 was $18,585 as compared to $15,877 for the period ended June 30, 2007.

Expenses  for the six  months  ended  June 30,  2008 were  primarily  accounting
($6,500) and interest on note payables (3,189).

Expenses for the six months ended June 30, 2007 were primarily accounting
($13,200) and interest on note payables ($2,427).

THREE MONTHS ENDED JUNE 30, 2008 AND JUNE 30, 2007
Development  stage  expenses and interest  expense during the three months ended
June 30, 2008 was $13,245 as compared to $7,939 for the three  months ended June
30, 2007.

Expenses  for the three  months  ended June 30, 2008 were  primarily  accounting
($5,000),  legal  ($5,000),  transfer  agent  services ($ 1,500) and interest on
notes payable (1,635).

Expenses  for the three  months  ended June 30, 2007 were  primarily  accounting


                                       12
<PAGE>



Liquidity and Capital Resources

Despite  capital  contributions  and both  related  party and third  party  loan
commitments,  the  company  from  time to time  experienced,  and  continues  to
experience, cash flow shortages that have slowed the Company's growth.

The Company has primarily financed its activities from sales of capital stock of
the Company and from loans from related and third parties. A significant portion
of the  funds  raised  from the sale of  capital  stock  has been  used to cover
working capital needs such as office expenses and various professional fees.

For the six months ended June 30, 2008,  we incurred a net loss of $18,585.  Our
accumulated  deficit since inception is $321,865.  Such accumulated  losses have
resulted primarily from costs related to various professional fees.

The Company  continues to experience cash flow shortages,  and anticipates  this
continuing through the foreseeable  future.  Management believes that additional
funding will be necessary  in order for it to continue as a going  concern.  The
Company is investigating  several forms of private debt and/or equity financing,
although  there can be no  assurances  that the Company  will be  successful  in
procuring such financing or that it will be available on terms acceptable to the
Company.




                                       13
<PAGE>


Item 4T. Controls and Procedures

         This   quarterly  report   does   not  include a report of management's
assessment  regarding  internal  control over  financial   reporting  due  to  a
transition  period  established  by  rules  of the   Securities   and   Exchange
Commission for newly public companies.

                                   PART II

Item 1.  Legal Proceedings.

         None.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

         None.

Item 3.  Defaults Upon Senior Securities.

         A  promissory  note  payable  in  the  amount  of  $24,409   became due
January 1, 2007 and  accordingly  is in default.


Item 4. Submission of Matters to a Vote of Security Holders.

         None.



                                       14

<PAGE>



Item 5. Other Information.

         None.

Item 6.  Exhibits.

Index to Exhibits.

3.1*              Articles of Incorporation

3.2*              Amendment No. 1 to Articles of Incorporation

3.3*              Amendment No. 2 to Articles of Incorporation

3.4*              By-laws

31.1              Rule 13(a) -- 14(a)/15(d) -- 14(a)  Certification   (Principal
                  Executive Officer)

31.2              Rule 13(a) -- 14(a)/15(d) -- 14(a)  Certification   (Principal
                  Financial Officer)

32.1              Section 1350 Certification (Principal Executive Officer)

32.2              Section 1350 Certification (Principal Financial Officer)

         *  Incorporated    by    Reference    to   the  Company's  Registration
Statement on Form 10-SB filed on November 13, 2007.



                                    SIGNATURES

         Pursuant    to   the    requirements   of  Section  13 or  15(d) of the
Securities  Exchange  Act of  1934,  the registrant has duly caused this  report
to be signed on its behalf by the undersigned, thereunto duly authorized.


                                     CENTRACAN INCORPORATED


Dated: August 19, 2008                  By: /s/Jerome Goubeaux
                                        ---------------------------------------
                                           Jerome Goubeaux,
                                           Chief Executive Officer and Director



                                       15